Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
29 apr 2008 - 09:19
Statutaire naam
Crucell N.V.
Titel
Crucell Announces STAR® Research License Agreement with Toyobo Gene Analysis Co. LTD.
Bericht
Leiden, The Netherlands, 29 April 2008 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a non-exclusive STAR® research license agreement with Toyobo Gene Analysis Co. LTD. Under the agreement, Toyobo Gene Analysis will evaluate Crucell’s STAR® technology for generating cell lines for the production of recombinant proteins for third-party customers. Financial details of the agreement were not disclosed.
Gerelateerde downloads
Datum laatste update: 01 september 2024